Single nucleotide polymorphism at alcohol dehydrogenase-1B is associated with risk of esophageal squamous cell carcinoma by Bo Ye et al.
Ye et al. Cancer Cell International 2014, 14:12
http://www.cancerci.com/content/14/1/12PRIMARY RESEARCH Open AccessSingle nucleotide polymorphism at alcohol
dehydrogenase-1B is associated with risk of
esophageal squamous cell carcinoma
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Background: Esophageal squamous incidence in many developed countries has increased dramatically over last
decades, while the underlying mechanism of the biogenesis of ES was still unknown.
Methods: Here, we investigate 1001 subjects with esophageal cancer recruited from the affiliated hospital of
Shanghai Jiao Tong University from Jan. 1, 2001 to Feb. 2, 2004. Single nucleotide polymorphism (SNP) of alcohol
dehydrogenase-1B (ADH1B) was performed, and the recombinant plasimd containing ADH1B was constructed.
Then, the ADH1B was purified and the enzymatic activity was assayed according to the methodology of Quayle.
Furthermore, the effect of ADH1B on proliferation of human esophageal squamous cell lines was determined and
the underlying mechanism of ADH1B was investigated.
Results: Logistic regression analyses revealed that subjects carrying the GG variant homozygote had a significant
2.81-fold (adjusted OR = 2.81; 95% CI = 2.18-3.62) increased risk of esophageal cancer. We found that SNP of ADH1B
(GG) significantly promotes cell proliferation in ESGG. ADH1B (GG) could down-regulate endogenous ADH1B expression
at posttranscriptional level. Moreover, re-expression of ADH1B in cells transfected with ADH1B (AA) significantly inhibits
cell proliferation.
Conclusions: Our data implied that ADH1B (GG) could promote cell proliferation in human ESGG through regulating
the enzyme activity of ADH1B. Therefore, we propose that ADH1B might be used as a therapeutic agent for human
ESGG.
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China was one of the countries with highest esophagus
cancer risk in the world [1]. A rapid increase in inci-
dence and mortality from esophageal adenocarcinoma
(EA) has been observed over the past four decades in
China [2]. Factors in the pathogenesis of esophageal can-
cer can be divided into the external cause and internal
cause: external cause is mainly refers to the external
stimulating factors [3] and internal cause is mainly refers
to the patient’s genetic factors [4]. Epidemiological stud-
ies indicate that use of tobacco and consumption of
alcohol are major risk factors for esophageal cancer [5].* Correspondence: zhangxuwy@hotmail.com
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reproduction in any medium, provided the orHowever, only a subset of individuals exposed to tobacco
and alcohol develop esophageal cancer, suggesting a role
of host susceptibility factors in cancer development.
Some studies have suggested that genetic polymorphisms
might explain individual differences in susceptibility to
esophageal cancer [6]. Esophageal cancer is often occurred
under the continuous effect of exogenous factors on in-
ternal factors.
Some subtypes of cancer are linked to particular risk
factors, such as age, sex, heredity and tobacco smoking
and heavy alcohol usage. Alcohol intake may be causally
related to cancer of the oral cavity, pharynx, larynx and
esophagus [7]. Ethanol is oxidized to acetaldehyde and
then to acetate by alcohol dehydrogenase (ADH) and
aldehyde dehydrogenase (ALDH); both of which have
genetic polymorphisms [8]. The genetic polymorphismsThis is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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differences in alcohol-oxidizing capability and drinking
behavior [9]. In humans, the major enzymes involved
in the alcohol‑metabolizing pathways are alcohol de-
hydrogenase 1B (ADH1B) and aldehyde dehydrogenase
2 (ALDH2). Alcohol is first oxidized by ADH to acetal-
dehyde, which is oxidized to acetate by ALDH. These
enzymes are mainly expressed in the liver, but are also
present in the gastrointestinal tract [10]. The gene en-
coding the ADH1B enzyme is located on chromosome
4q22, and the ADH1B gene (encoding for subunit β) is
the locus responsible for the majority of the ADH activ-
ity on ethanol in the liver [11]. ADH1B is a low Km
(Michaelis constant)-class enzyme and exhibits high ac-
tivity in catalyzing ethanol to acetaldehyde [12]. The
most frequently reported locus is ADH1B Arg47His
(rs1229984). In ADH1B His/His individuals, which are
associated with flushing or other reactions to alcohol,
the activity of ADH1B has been demonstrated to be de-
creased by 40-fold [13].
A recent genome-wide association study identified the
variation of ADH1B rs1229984 and ALDH2 rs671 poly-
morphisms as risk factors for esophageal cancer [14].
Another genome-wide association study reported that var-
iations of ADH1B rs1229984 and ALDH2 rs671 coupled
with alcohol drinking and smoking synergistically en-
hanced the risk of esophageal cancer [15]. We evaluated
the association between ADH1B genotypes and suscepti-
bility to esophageal cancer in a hospital-based case–con-
trol study. Genotyping analyses were conducted for the
two SNPs with 1001 ESGG cases and 1001 controls in a
Chinese population. Here, we provided evidence that
ADH1B rs1229984 GG is one of the risks to initiate the
Human esophageal cancer. Ectopic expression of ADH1B
was able to significantly inhibit esophageal cancer in vitro
and in vivo by increasing the consuming of alcohol. Fur-
thermore, we sought to investigate the associations be-
tween measures of ADH1B and risk of progression to
esophageal cancer in gene, protein and cellular level. This
study provide the specific therapeutic target genes for tar-
geting therapy in Human esophageal cancer. However, fur-
ther experiments are still needed to confirm our results.
Material and methods
Ethical approval of the study protocol
This hospital-based case–control study was sved by the
Ethic Committee of Shanghai Chest Hospital Affiliated
to Shanghai Jiao Tong University. All participating sub-
jects provided written informed consent prior to inclu-
sion in the study.
Study subjects
A total of 1001 subjects with esophageal cancer were
consecutively recruited from the affiliated hospital ofShanghai Jiao Tong University between Jan. 1, 2001 and
Feb. 2, 2004. All cases of esophageal cancer were diag-
nosed as ESGG by pathological means. The exclusion
criteria were patients who previously had cancer, any
metastasized cancer, radiotherapy or chemotherapy. The
controls were patients without cancer who were frequency-
matched to the cases with regard to age and gender, were
recruited from the two above mentioned hospitals during
the same period. The majority of control subjects had
trauma or infectious diseases. Each subject was personally
questioned by trained interviewers using a pre-tested ques-
tionnaire to obtain information on demographic data (e.g.,
age, gender) and related risk factors (including tobacco
smoking and alcohol consumption). Following the inter-
view, 2 ml samples of venous blood were collected from
each subject. Individuals who smoked one cigarette per day
for >1 year were defined as ‘smokers’. Subjects who con-
sumed ≥3 alcoholic drinks a week for 6 months were
considered to be ‘alcohol drinkers’.
Isolation of DNA and genotyping of ADH1B
Blood samples were collected from patients using Vacu-
tainers and transferred to tubes lined with ethylene
diamine tetra-acetic acid (EDTA). Genomic DNA was
isolated from whole blood using the QIAamp DNA
blood mini kit (Qiagen, Berlin, Germany). Genotyping was
conducted of ADH1B gene was performed using a PCR-
RFLP assay on a Gene Amp PCR System 9700 (Applied
Bio-systems). The amplification conditions for gene was as
follows: an initial denaturing step of 95°C for 5 min,
followed by 40 cycles of 95°C for 10 s, 60°C for 30 s, and
74°C for 45 s and a final elongation step of 74°C for 2 min.
PCR primers were designed for SNPs of the ADH1B
genes. ADH1B-specific allele was amplified with primer
set (ADH1B_RFLP_F: 5′-CCTTGGGGATAAACTGAAT
CTT-3′; ADH1B_RFLP_R: 5′-GAAATCCTGGATGGT
GAACC-3′; amplicon 348 bp). The reaction mixture con-
tained 7.5 ul of distilled water, 12.5 ul of 2X PCR buffer
for KOD plus, 2.5 ul of 2 mM dNTPs, 10 pmol each
primers for ADH1B, and 0.5 U of KOD plus polymerase.
Construction of recombinant plasmid containing ADH1B
Human ADH1B cDNA located between EcoR I and Not
I site of pUCm-T was cloned. According to the informa-
tion about SNPs in the human ADH1B gene, point mu-
tations were introduced into the wild-type ADH1B using
QuickChange site-directed mutagenesis kit (Stratagene).
We have generated the following three kinds of missense
mutations reported previously: AA, GG and AG. The
introduction of the mutations was verified by full se-
quencing. The ADH1B cDNA was sub-cloned into the
EcoR I and Not I site of pEASY-T1, resulting in the pro-
duction of pEASY-T1-ADH1B. pEASY-T1-ADH1B has
EcoR I and Not I sites upstream and downstream of the
Table 1 General information of esophageal cancer group
and control group
Esophageal cancer
(n = 1001) No. (%)
Health control
(n = 1391) No. (%)
P*
Sex 0.69
Male 795 (79.42) 1114 (80.09)
Female 206 (20.58) 277 (19.91)
Age (years) 0.46
40 30 (3.00) 47 (3.38)
41-60 539 (53.84) 778 (55.93)
>60 432 (43.16) 566 (40.69)
Smoking status 2.14 × 10-11
Non-smoker 337 (33.66) 651 (46.80)
Smoker 632 (63.14) 684 (49.17)
Unclear
situation
32 (3.20) 56 (4.03)
*Two-sided χ2 test.
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I digested fragments of pEASY-T1-ADH1B were ligated
with pPICZB, resulting in pPICZB-ADH1B. The recom-
bined plasmid was transfected by electroporation of Pichia
pastoris.
Enzyme purification and assays
Cells were harvested by centrifugation and washed with
50 mM Tris–HCl, pH8.0 (buffer A). The cell paste was
frozen at −20°C until further use. The cells were dis-
rupted with single passage through a French press oper-
ated at 20,000 lb/in2. The cellular debris was removed
centrifugation at 8, 000 × g for 30 min. Protein ADH1B
in the supernatant was purified by DEAE-Sepharose.
ADH1B activity was measured as the increase in A340
according to the method of Quayle [16], using 0.025%
Triton X-100-treated tuber or soluble proteins that were
extracted as previously described. 1) Add the ADH en-
zyme to each solution; 2) stop the ADH activity and cre-
ate a color reaction that indicates the alcohol that has
been broken down; 3) measure the amount of color pro-
duced in each tube using a spectrophotometer; 4) graph
the results by plotting the absorbance obtained for the
alcohol solutions.
Cell culture and transfection
Human ESGG cell line Eca109 was purchased from the
Shanghai Institute of Cell Biology (Shanghai, China).
Cells were maintained in RPMI1640 (Invitrogen), sup-
plemented with 10% fetal bovine serum (Invitrogen), 100
U/ml penicillin and 100 μg/ml streptomycin, within a
humidified atmosphere containing 5% CO2 at 37°C. 1 ×
106 cells cultured in a well of 6-well cell culture plate
were transiently transfected. ADH1B-flag of empty vec-
tor were generated by retroviral infection. Esophageal
squamous cell that constitutively expressed either Flag-
tagged ADH1B or empty vector were confirmed by west-
ern blot analysis with specific antibodies against ADH1B
and the Flag tag.
Cell proliferation assay and cell cycle
To determine the effect of the polymorphism of ADH1B
on proliferation of cancer cell lines, 4 × 103 cells were
transfected with ADH1B with mock control following
manufacturer’s protocol in 96-well plate. MTT assay was
performed at 24 h, 48 h and 72 h post transfection. The
absorbance of the samples was measured with spectro-
photometer reader at 490 nm. Each assay was performed
in triplicate and repeated three times independently.
MTT assay with alcohol pre-treatment
To determine the effect of ALDH1B on proliferation of
Human esophageal squamous cell lines, 1 × 105 cells were
transfected with ALDH1B gene (GG and AA). 2% ethanolwas added into the culture medium and negative control
group was set at 1%,2%,5%, respectively. MTT assay was
performed at 24 h, 48 h and 72 h post transfection. The
absorbance of the samples was measured with a spectro-
photometer reader at 490 nm. Each assay was performed
in triplicate and repeated three times independently.
Statistical analyses
Differences in the distributions of demographic charac-
teristics, selected variables and genotypes of ADH1B
variants between cases and normal controls were eva-
luated using the χ2 test. Associations between ADH1B
genotypes and the risk of esophageal cancer were esti-
mated by computing the odds ratios (ORs) and their
95% confidence intervals (CIs) using logistic regression
analyses for crude ORs and adjusted ORs when adjust-
ing for age, gender, tobacco use and drinking status.
The Hardy-Weinberg equilibrium was tested by a
goodness-of-fit χ2 test to compare the observed geno-
type frequencies to the expected among the control
subjects. All statistical analyses were conducted using
SAS 9.1.3 software (SAS Institute, Cary, NC, USA).
Results
Characteristics of the study population
Among the 1001 ESGG cases and the 1391 controls with
DNA samples, genotyping was successful in 1001 (100%)
cancer case and 1391 (100%) controls for ADH1B
rs1229984. Characteristics of cases and controls are
summarized in Table 1. Cases and controls appeared to
be adequately matched with respect to age and gender
as suggested by the x2 tests (p = 0.69 and p = 0.46,re-
spectively). No significant difference was observed with
Figure 1 Electrophoresis of genomic DNA after restriction endonuclease digestion. ADH1B rs1229984 A/A allele generated one fragment of
approximately 132 bp, G/G allele generated two bands of 112-bp and 20-bp, while the lanes containing both132 and 112 fragments represent
the allele is A/G.
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(p = 0.54). However, the prevalence of smoking was
higher in the esophageal cancer patients than in the con-
trol subjects (P < 0.005) (Table 1).
ADH1B rs1229984 polymorphisms and the risk of
esophageal cancer
Genotyping of ADH1B rs1229984 SNP was successfully
sequenced in all subjects. Some of the results from the
re-genotyped samples matched that from original ones
completely (Figure 1). The distribution of ADH1BFigure 2 DNA sequencing of rs1229984 SNP in ESCC patients and hears1229984 SNP (Figure 2) was not correlated with gen-
der and age both in ESCC patients or healthy controls
(data not shown). The genotype distribution in control
population was in agreement with those expected under
Hardy-Weinberg Equilibrium (HWE). The genotype
distributions of ADH1B in the cases and controls are
shown in Table 2. The observed genotype frequencies
for these two polymorphisms in the controls were all
within Hardy-Weinberg equilibrium (p = 0.68). In the
univariate analyses, the genotype frequencies of ADH1B
rs1229984 were 37.66% (AA), 39.96% (AG) and 22.38%lthy controls. A: genotype A/G; B: genotype G/G; C: genotype A/A.
Table 2 Gene frequency of rs1229984 (ADH1B) between esophageal cancer and control group
Genotype ESGG OR* (95% CI) P
Patients (n = 1001) No. (%) Controls (n = 1391) No. (%)
AA 377 (37.66) 663 (47.66) 1.00 (reference)
AG 400 (39.96) 578 (41.55) 1.20 (1.00–1.44) 0.06
GG 224 (22.38) 150 (10.79) 2.81 (2.18–3.62) 1.05 × 10-15
AG + GG 624 (62.34) 728 (52.34) 1.51 (1.28–1.80) 1.95 × 10-6
G allele frequency 42.36% 31.56%
Ptrend
† <0.01
*Data were calculated by logistic regression, adjusted for age, sex, smoking.
†Tests for trend of odds within genotypes of AA, AG, GG were two sided and based on likelihood ratio tests assuming a multiplicative model.
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and 10.79% (GG) in the control subjects. The difference
was revealed to be significant (p = 0.06). Logistic regres-
sion analyses revealed that subjects carrying the GG
variant homozygote had a significant 2.81-fold (adjusted
OR = 2.81; 95% CI = 2.18-3.62) increased risk of esopha-
geal cancer. In the recessive model, the ADH1B
rs1229984 GG variant homozygote was associated with
a 1.51-fold significantly increased risk of esophageal
cancer compared with rs1229984 AA/AG genotypes
(adjusted OR = 1.51, 95% CI = 1.28-1.80).Enzyme activity
One unit of enzyme activity was defined as the amount
which produced 1uM of NADH per min. The NADH
activity was assayed by monitoring the increase in ab-
sorbance at 340 nm due to the formation of NADH. The
enzyme was ADH1B activity can be varied according to
the Polymorphism of the rs1229984. The formaldehyde
accumulated during Enzyme activity dropped as we can
see from the Figure 3 and Figure 4.Figure 3 Enzyme activity of different genotype (AA and GG). *
represent statistical significance with p value < 0.05.ADH1B activity promote cell proliferation
To explore the role of ADH1B enzyme activity on the
proliferation of esophageal cancer cell line with Exogen-
ous of alcohol. The tolerance of cells with ADH1B
rs1229984 AA genotype was better than the rs1229984
GG genotype. The Alcohol Pre-treatment experiment
confirmed that the genotype of ADH1B rs1229984 was
significantly associated with the tolerance to alcohol
Pre-treatment. Collectedly, these results indicate that
ADH1B may play a role in the proliferation of esopha-
geal cancer cell line (Figure 5).
Discussion
We investigated the associated of ADH1B SNPs with risk
of esophageal cancer in a high-risk Chinese population.
Multivariable logistic analysis revealed that the ADH1B
rs1229984 GG genotype was associated with an increased
risk of esophageal cancer, and that this effect was more
evident among males, younger subjects and smokers. Our
results suggested a potential role of ADH1B SNPs on the
etiology of esophageal cancer.
Two recent genome-wide association studies identified
the variation of ADH1B rs1229984 as risk factors for
esophageal cancer in a Japanese population. However, in
another three genome-wide association studies in larger
Chinese populations, the results presented negative or
protective efforts of these polymorphisms for esophageal
cancer risk [17]. The reason for these inconsistent find-
ings for ADH1B rs1229984 polymorphisms is unknown.
However, variation in enzyme activity with ethnicity and
gender could contribute to differences in influences on
neoplasms. The genome instability induced by ethanol
and acetaldehyde mediated pathways could explain
ADH1B polymorphic effects on alcohol induced carcino-
genesis. In the present study, we also found a significant
gene environment interaction between ADH1B rs1229984
polymorphisms and smoking habit, suggesting susceptibil-
ity to esophageal cancer.
Alcoholic beverages may have carcinogenic effects on
humans and are causally related to cancer of the oral
Figure 4 Quantitative expression of ADH in genotype AA
and GG.
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morphisms of alcohol-metabolizing enzymes modulate
individual differences in alcohol-oxidizing capability and
drinking behavior. Genetic variants such as alcohol dehy-
drogenases (ADH) relates to average alcohol consumption
or circulating ethanol levels deserve our attention. ADHs
catalyze the oxidation of alcohols to aldehydes, which are
low Km (Michaelis constant)-class enzyme [18,19]. ThereFigure 5 ADH1B activity promote cell proliferations (AA and GG). *repare five ADH classes existing in humans [20] and func-
tional polymorphisms of ADH1B and ADH1C genes pro-
duce iso-enzymes with different maximal activities (Vmax)
and affinities for ethanol. One of the coding variant in
ADH1B is rs1229984, which leads to the replacement of
Arg48 with His48, is common in Asian populations and
the enzymes with His48 oxidize ethanol approximately
70- to 80-fold faster than those with Arg48, eventually
reduces their risk for alcoholism [21]. These results are
consistent with the recent analysis showed that AG (Arg/
His) or AA (His/His) phenotype exhibited higher activity
compared to GG (Arg/Arg).
To investigate the function connection of ADH1B
in the regulation of ESCC cell proliferation, we further
evaluate the proliferation capacity of cells transfected with
ADH1B (GG or AA) plasmid. Notably, cells contrasfected
with ADH1B (GG) had a significantly higher proliferative
index than those transfected with ADH1B (CC) plasmid.
Meanwhile, cells transfected with ADH1B (GG) exhibited
a significantly higher colony forming efficiency, as well as
a significantly shorter population doubling time than the
ADH1B (CC) cells (Figure 5). This result, combined
with the fact that the enzyme activity of ADH1B with
ADH1B (CC) in the cells was significantly higher than
that ADH1B (GG) (Figure 3 and Figure 4), suggest that
ADH1B might regulate the proliferation of ESCC cells
associated with enzyme activity.
In conclusion, the present study provided marked
evidence that functional polymorphism of ADH1B
rs1229984 may contribute to the risk of esophageal can-
cer. However, our results were obtained with a limited
sample size and therefore only preliminary conclusions
can be drawn. Besides, the underlying mechanisms of
ADH1B in regulating the proliferation of ESCC cell
warrant further investigation.resent statistical significance with p value < 0.05.
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